Skip to Content

Join the 'Effient' group to help and get support from people like you.

Effient News

Sickle Cell Drug Doesn't Relieve Pain Crises: Study

Posted 8 Dec 2015 by Drugs.com

TUESDAY, Dec. 8, 2015 – The anti-clotting drug prasugrel does little to reduce the risk of pain crises in children with sickle cell disease, a new study shows. The research included 341 patients in 13 countries in Africa, the Americas, Asia, Europe and the Middle East. About half took prasugrel (Effient) for between nine and 24 months. The other half took a placebo. There was little difference ...

Wide Variations Seen in U.S. Stroke Care

Posted 7 Jul 2015 by Drugs.com

TUESDAY, July 7, 2015 – Americans' odds of receiving a drug that can halt strokes in progress may vary widely depending on their ZIP codes, a new study finds. Experts said the findings, reported in the July issue of the journal Stroke, help verify what everyone has suspected: There are disparities in emergency stroke care across the United States, specifically in the use of a clot-busting drug ...

Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study

Posted 17 Nov 2014 by Drugs.com

MONDAY, Nov. 17, 2014 – Heart attack and stroke patients can safely take aspirin combined with a blood-thinning medication, new research confirms. The blood-thinning combination won't increase a patient's risk of early death, according to a new study presented Sunday at the annual meeting of the American Heart Association in Chicago. The report was also published online Nov. 16 in The Lancet. ...

FDA Medwatch Alert: Long-term Antiplatelet Therapy: Safety Announcement - Preliminary Trial Data Shows Benefits But a Higher Risk of Non-Cardiovascular Death

Posted 16 Nov 2014 by Drugs.com

[Posted 11/16/2014] ISSUE: FDA is evaluating preliminary data from a clinical trial showing that treatment for 30 months with dual antiplatelet blood-thinning therapy decreased the risk of heart attacks and clot formation in stents, but there was an increased overall risk of death compared to 12 months of treatment. The clinical trial compared 30 months versus 12 months of treatment with dual ...

Ask a Question

Further Information

Related Condition Support Groups

Myocardial Infarction - Prophylaxis, Acute Coronary Syndrome, Myocardial Infarction, Heart Attack

Effient Patient Information at Drugs.com